Publications and Presentations

Publications and Presentations

Rust, WL (2024, January). Pancreatic Islet Replacement Therapy: A Transformative Cure for Insulin-Requiring Diabetes. Biotech Showcase, San Francisco, CA, United States

Ratiu J, Southard SM, et al., 2023. Thetranscription factors ISL-1 and MAFA, but not NKX6-1 Characterize a Stem-cell Derived Population of Endocrine Pancreatic Cells Capable of Controlling blood Glucose in Rodent Models of Diabetes. Medical Research Archives 11i12.4797 (2023)

Jacob, A., Southard, S. & Rust, W. Cell Replacement Therapy for Insulin-Dependent Diabetes: Maintaining Islet Architecture and Distribution After Graft. Curr Transpl Rep 7, 99–104 (2020).

Rust, W. Regenerative Medicine Technologies Applied to Beta Cell Replacement: The Industry Perspective. In: Orlando G, Piemonti L, Ricordi C, Stratta RJ, and Gruessner RWG, (eds). Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas, Volume 2. San Diego: Elsevier Inc./Academic Press, 2020.

Welsch CA, Rust WL, Csete M. Concise Review: Lessons Learned from Islet Transplant Clinical Trials in Developing Stem Cell Therapies for Type 1 Diabetes. Stem Cells Transl Med. 2018 Nov 12.

Rust, WL (2017, March). Stem Cell cure for insulindependent diabetes: dreams versus reality. CDI International Diabetes Summit, Pune, India.

Rust, WL (2017, October). Development of a cell replacement therapy for insulin dependent diabetes: achievements and remaining challenges. Stem Cell Symposium, Baltimore, Maryland, United States.

Southard, S, Kotipatruni, R, Rust, W (2017, October). Long-term function of stem cell grafts for insulin-dependent diabetes. Stem Cell Symposium, Baltimore, Maryland, United States.

Southard, S, Kotipatruni, R, Rust, WL. Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents. PLOS 2018; 13(9). doi: 10.1371/journal.pone.0203126